Asymptomatic Bacteriuria: When to Treat and Antibiotic Selection in Pregnancy
Treatment of asymptomatic bacteriuria is indicated in only two clinical scenarios: pregnant women and patients undergoing urological procedures that breach the mucosa—all other populations should NOT be screened or treated.
When Treatment is Indicated
Pregnant Women (TREAT)
Screen for and treat asymptomatic bacteriuria in all pregnant women 1, 2, 3. This is the most important exception to the general rule of not treating ASB, as untreated bacteriuria increases the risk of pyelonephritis from 20-35% to only 1-4% with treatment 2. Treatment also reduces preterm delivery and low birth weight infants 2.
Screening approach:
- Obtain urine culture at least once in early pregnancy (ideally 12-16 weeks) 2
- Diagnosis requires ≥10⁵ CFU/mL on urine culture 2
- Perform periodic screening for recurrent bacteriuria following therapy 2
Urological Procedures Breaching Mucosa (TREAT)
Screen for and treat ASB before any urological procedure that breaches the mucosa 1. This includes transurethral resection of the prostate and similar procedures 2.
When Treatment is NOT Indicated (DO NOT TREAT)
The following populations should NOT be screened or treated for ASB 1, 3:
- Premenopausal, nonpregnant women
- Postmenopausal women
- Patients with well-regulated diabetes mellitus
- Elderly institutionalized patients
- Patients with dysfunctional/reconstructed lower urinary tract
- Renal transplant recipients (>1 month post-transplant)
- Patients before arthroplasty or cardiovascular surgery
- Patients with recurrent UTIs
- Catheterized patients while catheter remains in place
Important caveat: The presence of pyuria with ASB is NOT an indication for treatment 2.
Antibiotic Recommendations for Pregnant Patients
First-Line Options
Single-dose fosfomycin trometamol 3g is recommended as a treatment option 1. This provides the advantage of single-dose therapy with good efficacy 4.
Nitrofurantoin:
- 50-100 mg four times daily for 5 days, OR
- 100 mg twice daily for 5 days 1
Note: Avoid trimethoprim in first trimester and trimethoprim-sulfamethoxazole in last trimester of pregnancy 1.
Alternative Options
- Cephalosporins (e.g., cefadroxil 500 mg twice daily for 3 days) if local E. coli resistance <20% 1
- Cephalexin 5
- Sulfisoxazole 5
Ampicillin should NOT be used due to high resistance rates 5.
Treatment Duration
Recommend 4-7 days of antimicrobial treatment rather than shorter courses 3. While the 2024 EAU guidelines suggest standard short-course treatment or single-dose fosfomycin 1, the optimal duration varies by antimicrobial agent. One study demonstrated that a 7-day course of nitrofurantoin was superior to single-dose therapy, with less persistent infection 4.
The evidence shows that longer courses (7 days) prevent more persistent infections compared to 1-day courses, though there is insufficient evidence to definitively recommend among single-dose, 3-day, 4-day, or 7-day regimens 2. Use the shortest effective course for the chosen antimicrobial.
Key Clinical Pitfalls to Avoid
Do not treat ASB in diabetic women—multiple studies show no benefit and increased harm from antimicrobial exposure 2
Do not confuse delirium/confusion in elderly patients with UTI—assess for other causes rather than treating bacteriuria 3
Do not continue screening all pregnant women throughout pregnancy—insufficient evidence supports repeated screening after initial negative culture 3
Do not treat catheter-associated ASB while catheter remains in place—only consider treatment if bacteriuria persists 48 hours after catheter removal 2
The rationale for selective treatment is that ASB may actually protect against symptomatic UTI in most populations 1, and unnecessary antibiotic treatment increases antimicrobial resistance, Clostridioides difficile infection risk, and adverse drug effects without demonstrable benefit 3.